Cargando…
Left ventricle remodeling predicts the recurrence of ventricular tachyarrhythmias in implantable cardioverter defibrillator recipients for secondary prevention
BACKGROUND: Implantable cardioverter defibrillator (ICD) is an effective treatment for secondary prevention of ventricular tachycardia/ventricular fibrillation (VT/VF). Left ventricular (LV) remodeling may develop before ICD implant and over time. However, it remains unclear how LV remodeling affect...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117501/ https://www.ncbi.nlm.nih.gov/pubmed/27871248 http://dx.doi.org/10.1186/s12872-016-0416-y |
_version_ | 1782468814725709824 |
---|---|
author | Lee, Wei-Chieh Chen, Huang-Chung Chen, Yung-Lung Tsai, Tzu-Hsien Pan, Kuo-Li Lin, Yu-Sheng Chen, Mien-Cheng |
author_facet | Lee, Wei-Chieh Chen, Huang-Chung Chen, Yung-Lung Tsai, Tzu-Hsien Pan, Kuo-Li Lin, Yu-Sheng Chen, Mien-Cheng |
author_sort | Lee, Wei-Chieh |
collection | PubMed |
description | BACKGROUND: Implantable cardioverter defibrillator (ICD) is an effective treatment for secondary prevention of ventricular tachycardia/ventricular fibrillation (VT/VF). Left ventricular (LV) remodeling may develop before ICD implant and over time. However, it remains unclear how LV remodeling affects subsequent risk for recurrence VT/VF in ICD recipients under optimal medical therapy. METHODS: From May of 2004 to June of 2015, 144 patients received ICD implantation for secondary prevention were enrolled in this study. All information interrogated from ICD devices during follow-up or ICD therapy history (anti-tachycardia pacing and shock therapy) were reviewed and validated the occurrences of VT/VF. RESULTS: At a mean follow-up of 1110.5 ± 860.6 days, 53 patients (36.8%) had recurrence of VT/VF episodes and 91 patients had no recurrence of VT/VF episode after ICD implant. Left ventricular end-diastolic volume (LVEDV) > 163.5 mL had significant predictive value for VT/VF recurrence (area under the curve: 0.602, p = 0.041). Moreover, the percentage of patients with LVEDV >163.5 mL was significantly higher in patients with recurrent VT/VF than patients without recurrent VT/VF (62.3 vs 40.0%, p = 0.010). Left ventricular ejection fraction ≤ 30% (p = 0.031), LVEDV > 163.5 mL (p = 0.012) and QRS width > 125 msec (p = 0.049) were significant predictors for VT/VF recurrence by univariate Cox regression analysis. However, only LVEDV > 163.5 mL (hazard ratio: 2.549, 95% confidence interval: 1.249 ~ 5.201, p = 0.010) and QRS width > 125 msec (hazard ratio: 2.173, 95% confidence interval: 1.030 ~ 4.586, p = 0.042) were independent predictors for recurrence of VT/VF after multivariable adjustment. CONCLUSION: LV remodeling and QRS width > 125 msec were independent predictors for VT/VF recurrence in secondary prevention ICD recipients under optimal medical therapy, independent of LV ejection fraction. |
format | Online Article Text |
id | pubmed-5117501 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-51175012016-11-28 Left ventricle remodeling predicts the recurrence of ventricular tachyarrhythmias in implantable cardioverter defibrillator recipients for secondary prevention Lee, Wei-Chieh Chen, Huang-Chung Chen, Yung-Lung Tsai, Tzu-Hsien Pan, Kuo-Li Lin, Yu-Sheng Chen, Mien-Cheng BMC Cardiovasc Disord Research Article BACKGROUND: Implantable cardioverter defibrillator (ICD) is an effective treatment for secondary prevention of ventricular tachycardia/ventricular fibrillation (VT/VF). Left ventricular (LV) remodeling may develop before ICD implant and over time. However, it remains unclear how LV remodeling affects subsequent risk for recurrence VT/VF in ICD recipients under optimal medical therapy. METHODS: From May of 2004 to June of 2015, 144 patients received ICD implantation for secondary prevention were enrolled in this study. All information interrogated from ICD devices during follow-up or ICD therapy history (anti-tachycardia pacing and shock therapy) were reviewed and validated the occurrences of VT/VF. RESULTS: At a mean follow-up of 1110.5 ± 860.6 days, 53 patients (36.8%) had recurrence of VT/VF episodes and 91 patients had no recurrence of VT/VF episode after ICD implant. Left ventricular end-diastolic volume (LVEDV) > 163.5 mL had significant predictive value for VT/VF recurrence (area under the curve: 0.602, p = 0.041). Moreover, the percentage of patients with LVEDV >163.5 mL was significantly higher in patients with recurrent VT/VF than patients without recurrent VT/VF (62.3 vs 40.0%, p = 0.010). Left ventricular ejection fraction ≤ 30% (p = 0.031), LVEDV > 163.5 mL (p = 0.012) and QRS width > 125 msec (p = 0.049) were significant predictors for VT/VF recurrence by univariate Cox regression analysis. However, only LVEDV > 163.5 mL (hazard ratio: 2.549, 95% confidence interval: 1.249 ~ 5.201, p = 0.010) and QRS width > 125 msec (hazard ratio: 2.173, 95% confidence interval: 1.030 ~ 4.586, p = 0.042) were independent predictors for recurrence of VT/VF after multivariable adjustment. CONCLUSION: LV remodeling and QRS width > 125 msec were independent predictors for VT/VF recurrence in secondary prevention ICD recipients under optimal medical therapy, independent of LV ejection fraction. BioMed Central 2016-11-21 /pmc/articles/PMC5117501/ /pubmed/27871248 http://dx.doi.org/10.1186/s12872-016-0416-y Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Lee, Wei-Chieh Chen, Huang-Chung Chen, Yung-Lung Tsai, Tzu-Hsien Pan, Kuo-Li Lin, Yu-Sheng Chen, Mien-Cheng Left ventricle remodeling predicts the recurrence of ventricular tachyarrhythmias in implantable cardioverter defibrillator recipients for secondary prevention |
title | Left ventricle remodeling predicts the recurrence of ventricular tachyarrhythmias in implantable cardioverter defibrillator recipients for secondary prevention |
title_full | Left ventricle remodeling predicts the recurrence of ventricular tachyarrhythmias in implantable cardioverter defibrillator recipients for secondary prevention |
title_fullStr | Left ventricle remodeling predicts the recurrence of ventricular tachyarrhythmias in implantable cardioverter defibrillator recipients for secondary prevention |
title_full_unstemmed | Left ventricle remodeling predicts the recurrence of ventricular tachyarrhythmias in implantable cardioverter defibrillator recipients for secondary prevention |
title_short | Left ventricle remodeling predicts the recurrence of ventricular tachyarrhythmias in implantable cardioverter defibrillator recipients for secondary prevention |
title_sort | left ventricle remodeling predicts the recurrence of ventricular tachyarrhythmias in implantable cardioverter defibrillator recipients for secondary prevention |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117501/ https://www.ncbi.nlm.nih.gov/pubmed/27871248 http://dx.doi.org/10.1186/s12872-016-0416-y |
work_keys_str_mv | AT leeweichieh leftventricleremodelingpredictstherecurrenceofventriculartachyarrhythmiasinimplantablecardioverterdefibrillatorrecipientsforsecondaryprevention AT chenhuangchung leftventricleremodelingpredictstherecurrenceofventriculartachyarrhythmiasinimplantablecardioverterdefibrillatorrecipientsforsecondaryprevention AT chenyunglung leftventricleremodelingpredictstherecurrenceofventriculartachyarrhythmiasinimplantablecardioverterdefibrillatorrecipientsforsecondaryprevention AT tsaitzuhsien leftventricleremodelingpredictstherecurrenceofventriculartachyarrhythmiasinimplantablecardioverterdefibrillatorrecipientsforsecondaryprevention AT pankuoli leftventricleremodelingpredictstherecurrenceofventriculartachyarrhythmiasinimplantablecardioverterdefibrillatorrecipientsforsecondaryprevention AT linyusheng leftventricleremodelingpredictstherecurrenceofventriculartachyarrhythmiasinimplantablecardioverterdefibrillatorrecipientsforsecondaryprevention AT chenmiencheng leftventricleremodelingpredictstherecurrenceofventriculartachyarrhythmiasinimplantablecardioverterdefibrillatorrecipientsforsecondaryprevention |